Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis.
Fiche publication
Date publication
janvier 2015
Journal
European neurology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MOULIN Thierry
Tous les auteurs :
Magnin E, Sagawa Y, Chamard L, Berger E, Moulin T, Decavel P
Lien Pubmed
Résumé
Fampridine is sometimes reported to improve cognition and especially the information-processing speed. Motor improvement might be a confounding factor. The aim of this study was to evaluate the effects of fampridine on verbal fluencies in patients with multiple sclerosis (MS).
Mots clés
4-Aminopyridine, therapeutic use, Adult, Cognition Disorders, drug therapy, Disability Evaluation, Female, France, Gait Apraxia, drug therapy, Humans, Male, Middle Aged, Multiple Sclerosis, drug therapy, Prospective Studies, Speech Disorders, drug therapy, Speech Production Measurement, Verbal Behavior, drug effects
Référence
Eur Neurol. 2015 ;74(5-6):243-50